Cargando…
Association of a Single-Nucleotide Variant rs11100494 of the NPY5R Gene with Antipsychotic-Induced Metabolic Disorders
Background: The usage of antipsychotics (APs) is the most robust and scientifically based approach in the treatment of schizophrenia spectrum disorders (SSDs). The efficiency of APs is based on a range of target receptors of the central nervous system (CNS): serotoninergic, dopaminergic, adrenergic,...
Autores principales: | Dobrodeeva, Vera S., Shnayder, Natalia A., Novitsky, Maxim A., Asadullin, Azat R., Vaiman, Elena E., Petrova, Marina M., Limankin, Oleg V., Neznanov, Nikolay G., Garganeeva, Natalia P., Nasyrova, Regina F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876767/ https://www.ncbi.nlm.nih.gov/pubmed/35213955 http://dx.doi.org/10.3390/pharmaceutics14020222 |
Ejemplares similares
-
Genetic Predisposition to Schizophrenia and Depressive Disorder Comorbidity
por: Shnayder, Natalia A., et al.
Publicado: (2022) -
Genetic Biomarkers of Antipsychotic-Induced Prolongation of the QT Interval in Patients with Schizophrenia
por: Vaiman, Elena E., et al.
Publicado: (2022) -
Single-Nucleotide Polymorphisms as Biomarkers of Antipsychotic-Induced Akathisia: Systematic Review
por: Nasyrova, Regina F., et al.
Publicado: (2023) -
Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome
por: Khasanova, Aiperi K., et al.
Publicado: (2022) -
Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
por: Vaiman, Elena E., et al.
Publicado: (2021)